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Allan L. Klein, MD,e Sherif F. Nagueh, MDcABSTRACTBACKGROUND The diagnosis of heart failure may be challenging because symptoms are rather nonspeciﬁc. Elevated
left ventricular (LV) ﬁlling pressure may be used to conﬁrm the diagnosis, but cardiac catheterization is often not
practical. Echocardiographic indexes are therefore used as markers of ﬁlling pressure.
OBJECTIVES This study investigated the feasibility and accuracy of comprehensive echocardiography in identifying
patients with elevated LV ﬁlling pressure.
METHODS We conducted a multicenter study of 450 patients with a wide spectrum of cardiac diseases referred for
cardiac catheterization. Left atrial volume index, in combination with ﬂow velocities and tissue Doppler velocities, was
used to estimate LV ﬁlling pressure. Invasively measured pressure was used as the gold standard.
RESULTS Mean left ventricular ejection fraction (LVEF) was 47%, with 209 patients having an LVEF <50%. Invasive
measurements showed elevated LV ﬁlling pressure in 58% of patients. Clinical assessment had an accuracy of 72% in
identifying patients with elevated ﬁlling pressure, whereas echocardiography had an accuracy of 87% (p < 0.001 vs.
clinical assessment). The combination of clinical and echocardiographic assessment was incremental, with a net reclas-
siﬁcation improvement of 1.5 versus clinical assessment (p < 0.001).
CONCLUSIONS Echocardiographic assessment of LV ﬁlling pressure is feasible and accurate. When combined with
clinical data, it leads to a more accurate diagnosis, regardless of LVEF. (J Am Coll Cardiol 2017;69:1937–48)
© 2017 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).H eart failure (HF) is a major public healthproblem that accounts for >1 million hospi-talization discharges annually in the United
States (1) and nearly as many emergency room visits
(2). For patients presenting with dyspnea, the clinical
diagnosis can be challenging because HF symptoms
are relatively nonspeciﬁc and may be due to noncar-
diac disease. In that regard, cardiac imaging can be
helpful for reaching the correct diagnosis and subse-
quently guiding patient management. Echocardiogra-
phy is usually the ﬁrst imaging test to obtain, as it
provides immediate information on left ventricular
(LV) size and function, including ejection fraction
(EF) and valvular function (3). However, the presence
of normal EF does not exclude a cardiac etiology for
dyspnea, as approximately 50% of patients with HF
have only mildly reduced EF or preserved EF (heart
failure with preserved ejection fraction [HFpEF]) (4).
A diagnostic hallmark of HF is elevated LV ﬁllingpressure, a compensatory response to maintain
cardiac output that is observed regardless of LVEF.
Information about ﬁlling pressure is important not
only to diagnose HF, but also to better appreciate its
severity and, subsequently, the response to treat-
ment. Although cardiac catheterization remains the
gold standard, it is not practical to submit many pa-
tients presenting with dyspnea and suspicion of HF to
invasive studies. Accordingly, there is a continuing
search for noninvasive markers of elevated LV ﬁlling
pressure. In that regard, there are recent guide-
lines on how to apply echocardiography to estimate
LV ﬁlling pressures that are based on expert
consensus but have not been validated against inva-
sively measured ﬁlling pressure (5). This multicenter
study sought to evaluate the feasibility and accuracy
of echocardiographic parameters recommended in
recent clinical practice guidelines in identifying
the presence of elevated LV ﬁlling pressure and
AB BR E V I A T I O N S
AND ACRONYM S
2D = 2-dimensional
A = mitral inﬂow peak late
diastolic velocity
AUC = area under the receiver-
operating characteristic curve
E = mitral inﬂow peak early
diastolic velocity
e0 = mitral annulus early
diastolic velocity
EF = ejection fraction
HFpEF = heart failure with
preserved ejection fraction
IDI = integrated discrimination
improvement
LV = left ventricular
PCWP = pulmonary capillary
wedge pressure
pre-A = pre-atrial contraction
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1939to determine the incremental value of combined
echocardiographic and clinical assessment for esti-
mating LV ﬁlling pressure.
METHODS
The multicenter study sites included Methodist
DeBakey Heart and Vascular Center (Houston, Texas),
McMaster University (Hamilton, Ontario, Canada),
Oslo University Hospital (Oslo, Norway), Yonsei Uni-
versity Severance Hospital (Seoul, South Korea), and
the Cleveland Clinic (Cleveland, Ohio). Echocardiog-
raphy was performed in 450 patients referred for
right- and/or left-sided heart catheterization (180
patients from previous studies [6–8] and 270 patients
included prospectively), either during or immediately
post-procedure and without intervening clinical
change or administration of medications. Catheteri-
zation was obtained to help guide diagnosis and pa-
tient management. All patients age >18 years were
included if willing and able to give informed consent.
Patients with prior cardiac transplantation or complex
congenital heart disease that limited the application
of standard 2-dimensional (2D) echocardiography
Doppler methodology were excluded.SEE PAGE 1949Clinical data were evaluated by an experienced
cardiologist. The evaluation, based on chart review,
determined whether patients were in HF or not given
their symptoms (exertional dyspnea, paroxysmal
nocturnal dyspnea, orthopnea); physical examination
ﬁndings (S3, pulmonary rales, increased jugular
venous pressure, hepatomegaly, hepatojugular
reﬂux, and pedal edema or anasarca); additional tests
(such as electrocardiography for rhythm analysis and
evidence of LV hypertrophy, acute coronary syn-
drome, or old myocardial infarction; or chest x-ray to
look for cardiomegaly, pulmonary congestion, pul-
monary edema, or pulmonary inﬁltrates); laboratory
tests for abnormally elevated biomarkers; plus past
and present medical history, blinded to invasive
measurements of LV ﬁlling pressure and echocardio-
graphic estimation of LV ﬁlling pressure. We investi-
gated whether the available clinical information
could be used to determine whether LV ﬁlling pres-
sure was elevated. Echocardiographic data (2D and
Doppler) were applied to estimate LV ﬁlling pressure
as recommended in recent guidelines (5).
ECHOCARDIOGRAPHIC IMAGING AND ANALYSIS. Pa-
tients were imaged with ultrasound systems equip-
ped with multifrequency transducers. A complete
echocardiographic study was performed using stan-
dard views, with care taken to avoid foreshortening.From the apical window, pulsed wave
Doppler was used to record mitral inﬂow for 3
to 5 cardiac cycles at the level of the mitral
valve annulus and at the mitral tips. Pulmo-
nary venous ﬂow was recorded from 1 of the
pulmonary veins, guided by color Doppler.
Tissue Doppler was applied to record mitral
annular velocities at the septal and lateral
sides of the annulus. The resulting annular
velocities by pulsed wave Doppler were
recorded for 3 to 5 cardiac cycles at a sweep
speed of 100 mm/s. Tricuspid regurgitation
signals were recorded by continuous wave
Doppler from multiple windows. Saline
contrast was used in 11 patients, and echo-
cardiographic contrast was injected intrave-
nously in another 11 patients. It was feasible
to record inferior vena caval diameter (IVC)
and its collapse and hepatic venous ﬂow from
the subcostal view in 314 patients. The Central
Illustration shows a schematic illustration of the
parameters used to estimate LV ﬁlling pressure (5).
Measurements were performed on computerized
off-line analysis stations without knowledge of inva-
sively derived hemodynamic data. LV volumes, EF,
and left atrial (LA) maximal volume were measured as
recently recommended (9). Right ventricular function
and valvular regurgitation were evaluated following
American Society of Echocardiography (ASE) recom-
mendations (10,11). Mitral inﬂow from tips level was
analyzed for peak early diastolic velocity (E) as well as
late diastolic velocity (A), E/A ratio, and deceleration
time. Pulmonary venous ﬂow was analyzed for the
peak velocity of systolic, diastolic, and atrial reversal
signals. The ratio between pulmonary vein peak sys-
tolic and diastolic velocity and the difference in
duration between pulmonary vein atrial reversal ve-
locity and mitral A velocity were obtained (5). Mitral
annulus early diastolic velocity (e0) and late diastolic
velocity were measured at septal and lateral mitral
annulus and E/e0 ratios were computed. Interobserver
error (mean  SD) for mitral E velocity was 4  3%,
and for annulus e0 velocity was 5  2%. Intraobserver
error (mean  SD) for mitral E velocity was 3  2% and
for annulus e0 velocity was 3  2% (analysis repro-
ducibility). Measurements were averaged over 3 car-
diac cycles when patients had sinus rhythm, and over
5 cycles for patients in atrial ﬁbrillation (AF).
CARDIAC CATHETERIZATION. Mean right atrial
pressure, pulmonary artery pressures (systolic, dia-
stolic, and mean), and pulmonary capillary wedge
pressure (PCWP) were measured with a pulmonary
artery catheter during right heart catheterization in
CENTRAL ILLUSTRATION Noninvasive Assessment of LV Filling Pressure
Andersen, O.S. et al. J Am Coll Cardiol. 2017;69(15):1937–48.
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TABLE 1 Clinical, Echocardiographic, and Hemodynamic
Characteristics
Age, yrs 59.00  11.65
Male, % 61
Body surface area, m2 1.95  0.25
Diabetes mellitus 47 (10.4)
Chronic kidney disease 46 (10.2)
Hypertension* 139 (31.0)
Coronary artery disease† 117 (26.0)
LV end-diastolic volume, ml 154  90
LVEF, % 47  21
LAV index, ml/m2 (n ¼ 445) 45  27
E/A (n ¼ 387) 1.6  1.1
E/e0 (n ¼ 437) 13.9  7.5
Heart rate, beats/min 75  15
Stroke volume, ml 61  24
Cardiac output, l/min 4.5  1.8
Cardiac index, l/min/m2 2.3  0.9
Systolic blood pressure, mm Hg 126  24
Diastolic blood pressure, mm Hg 73  14
Pulmonary artery systolic pressure, mm Hg 47  19
Pulmonary artery diastolic pressure, mm Hg 20  9
Pulmonary capillary wedge pressure, mm Hg 17  9
LV end-diastolic pressure, mm Hg 21  9
Mean right atrial pressure, mm Hg 10  7
Values are mean  SD, %, or n (%). *On medications and/or having hypertension
at time of study. †Indicated by wall motion abnormalities and coronary angiog-
raphy results.
E/A ¼ mitral early diastolic velocity/atrial diastolic velocity ratio; E/e0 ¼ mitral
early diastolic velocity/average early diastolic e0 velocity ratio; LAV ¼ left atrial
volume; LV ¼ left ventricular; LVEF ¼ left ventricular ejection fraction.
TABLE 2 Correlation of 2D and Doppler Measurements With
LV Filling Pressure
r p Value
Left atrial maximal volume index 0.23 <0.0001
Mitral E velocity 0.44 <0.0001
Mitral A velocity 0.28 <0.0001
Mitral E/A ratio 0.53 <0.0001
Deceleration time of mitral E velocity 0.42 <0.0001
Isovolumic relaxation time 0.44 <0.0001
Pulmonary veins: systolic velocity/diastolic
velocity ratio
0.57 <0.0001
Pulmonary veins: atrial reversal
duration-mitral A duration
0.39 <0.0001
Septal E/e0 ratio 0.46 <0.0001
Lateral E/e0 ratio 0.5 <0.0001
Average E/e0 ratio 0.52 <0.0001
Doppler pulmonary artery systolic pressure 0.58 <0.0001
2D ¼ 2-dimensional; other abbreviations as in Table 1.
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1941293 patients. The wedge position was veriﬁed by
ﬂuoroscopy, changes in the waveform, and when
needed, changes in pulmonary vein oxygen satura-
tion (O2 saturation >95%). Invasive measurements
were acquired without knowledge of echo data. All of
them were derived at end expiration at an average of
5 cycles. Fluid-ﬁlled transducers were balanced
before the study with the 0 level at the midaxillary
line. Cardiac output (average of 3 cycles with <10%
variation in patients in sinus rhythm and 5 cardiac
cycles in patients with AF) was derived by thermo-
dilution only or both thermodilution and the FickCENTRAL ILLUSTRATION Continued
Elevated left ventricular (LV) ﬁlling pressure may be used to conﬁrm a d
instead of cardiac catheterization for such a conﬁrmation. (A) Of the ec
pulmonary artery pressure, the early diastolic mitral annulus velocity (e
pressures, and left atrial volume index is related to left atrial pressure (L
from recent guidelines (5), setting criteria of elevated LV ﬁlling pressures
3 parameters shown must be above cutoff values (table in A). The algori
LVEF but with myocardial disease. Echocardiography had an accuracy o
echocardiographic assessment demonstrated a net reclassiﬁcation impro
atrial diastolic velocity ratio; E/e0 ¼ mitral early diastolic velocity/averamethod using nomograms for oxygen uptake in
conjunction with the Fick method. When a discrep-
ancy was present between both methods, cardiac
output by thermodilution was used. In 157 patients,
left heart catheterization only was performed and LV
diastolic pressures were obtained. In these 157 pa-
tients, LV pre-atrial contraction (pre-A) pressure was
measured and used as an estimate of PCWP, as PCWP
and LV pre-A are known to correlate well (12). All
patients in AF (except for 2 cases) underwent right
heart catheterization, and PCWP measurements were
used for analysis, whereas mid-LV diastolic pressure
was used in the 2 patients who underwent left heart
catheterization only. PCWP or LV pre-A pressure
>12 mm Hg was considered abnormally elevated (13).
STATISTICAL ANALYSIS. Baseline characteristics are
presented as mean  SD for continuous variables or
numbers (percentage) for categorical variables. Ac-
curacy and 95% conﬁdence interval of comprehensive
echocardiography in detecting elevated PCWP and
clinical assessment versus echocardiography Doppleriagnosis of heart failure. We sought to determine if echocardiographic indexes could be used
hocardiographic parameters used, tricuspid regurgitation velocity is related to peak systolic
0) and the early (E) and atrial induced (A) mitral inﬂow velocities are related to LV diastolic
AP). (B) In the algorithm to estimate LV ﬁlling pressure, we incorporated recommendations
as either E/A ratio$2 in the presence of myocardial disease, or if E/A is <2, at least 2 of the
thm was applied in patients with depressed left ventricular ejection fraction (LVEF) or normal
f 87% versus 72% for clinical assessment (p < 0.001), and the combination of clinical and
vement of 1.5 versus clinical assessment (p < 0.001). E/A ¼ mitral early diastolic velocity/
ge early diastolic e0 velocity ratio.
FIGURE 1 Assessment: Patient With Depressed LVEF
Mitral inflow velocity Mitral annular velocity
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(Upper panel) Obtained during right heart catheterization, echocardiographic images demonstrated elevated left ventricular (LV) ﬁlling
pressure: mitral inﬂow velocities showed a restrictive ﬁlling pattern; average E/e0 ratio was 21; peak tricuspid regurgitation (TR) velocity was
3.7 m/s; and left atrial (LA) maximal volume index was 61 ml/m2. (Lower panel) Pressure recordings obtained during right heart catheteri-
zation showed pulmonary capillary wedge pressure (PCWP) was 27 mm Hg. E/e0 ¼ mitral early diastolic velocity/average early diastolic e0
velocity ratio; LVEF ¼ left ventricular ejection fraction.
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1942were calculated, and the McNemar test was used to
compare the accuracy. Area under the receiver-
operating characteristic curve (AUC) was calculated
from logistic regression analysis and compared using
the DeLong method. Regression analysis was used to
relate Doppler variables to LV ﬁlling pressure. Anal-
ysis of variance on ranks was used to compare LV
ﬁlling pressure among the 3 grades of diastolic
dysfunction, and Dunn’s method was used for pair-
wise comparisons. Global chi-square analysis deter-
mined the incremental value of the combination of
clinical assessment and echocardiography over
either alone in identifying patients with elevated
LV ﬁlling pressure. The increased discriminative
value of the combination of clinical assessment andechocardiography was examined with net reclassiﬁ-
cation improvement and integrated discrimination
improvement (IDI) methods. All analyses were per-
formed with STATA version 14 (StataCorp, College
Station, Texas). Statistical signiﬁcance was deﬁned as
a 2-tailed p < 0.05 for all tests.
RESULTS
PATIENT POPULATION. Table 1 presents a summary
of the clinical, echocardiographic, and hemodynamic
data of the study population. Mean LVEF was 47%,
with normal right ventricular function in 68% of pa-
tients. LVEF was <50% in 209 of 450 patients
(46.4%). Elevated LV ﬁlling pressure was seen in 58%
FIGURE 2 Assessment: Patient With Normal LVEF
Mitral inflow velocity
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Left atrial volume
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(Upper panel) Mean PCWP was 25 mm Hg. The prominent “a” and “v” waves are elevated above the mean pressure. (Lower panel) The
enlarged LA had a maximal volume index of 51 ml/m2. Mitral annulus e0 velocity (average of the 3 beats) is reduced at 5 cm/s, and E/e0 ratio is
15. Although the TR jet was incomplete, the other parameters—mitral annulus e0 velocity was 5 cm/s and E/e0 ratio was 15—and the presence of
2 of 3 variables meeting cutoff values was consistent with elevated LV ﬁlling pressure. Abbreviations as in Figure 1.
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1943of patients, mean PCWP was 17  9 mm Hg, and mean
LV pre-A pressure in the patients who underwent left
heart catheterization was 15  8 mm Hg. Elevated
LV ﬁlling pressure, as veriﬁed by invasive pressure
measurements, was present in 60% of patients with
EFs <50% and in 57% of patients with EFs $50%.
Moderately severe or severe mitral regurgitation (MR)
was present in 19 patients (elevated LV ﬁlling pressure
in 14 but normal in 5 patients), aortic stenosis of at
least moderate severity in 8 patients, pulmonary
parenchymal or vascular disease (type I pulmonary
arterial hypertension) in 71 patients, and end-stage
liver disease in 5 patients. The majority were in sinus
rhythm, with 41 patients having left bundle branch
block (LBBB) or paced rhythm and 18 patients with AF.PERFORMANCE OF INDIVIDUAL DOPPLER AND 2D
PARAMETERS. When all patients were considered,
signiﬁcant correlations were observed between 2D
and Doppler signals and LV ﬁlling pressure (Table 2).
Figures 1 and 2 show examples of echocardiography
Doppler and pressure recordings. For average E/e0
ratio, the correlation coefﬁcient (r ¼ 0.65; p < 0.0001)
(Figure 3) was higher in patients who were not in
LBBB or on ventricular pacing and who did not have
signiﬁcant MR (r ¼ 0.48; p < 0.01). The relation of LA
maximal volume index with LV ﬁlling pressure was
unchanged when patients in AF were excluded.
Using the cutoff values recommended in the recent
guidelines (5), the distribution of mitral E/A ratio, E/e0
ratio, LA maximal volume index, and peak tricuspid
FIGURE 3 Regression Plot: LV Filling Pressure
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Regression plots demonstrated the relation between LV ﬁlling pressure and either (upper
panel) average E/e0 ratio (patients with normal LV ejection fraction [EF] and depressed
LVEF are included in the plot but patients in left bundle branch block, paced rhythm, and
signiﬁcant mitral regurgitation were excluded) or (lower panel) LA maximal volume
index. Abbreviations as in Figure 1.
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1944regurgitation velocity identiﬁed patients with
elevated LV ﬁlling pressure (Table 3) excluding pa-
tients with moderately severe or severe MR, paced
rhythm, and AF (which have different algorithms) and
the 31 patients where the method was inconclusive.
To investigate the accuracy of the algorithm in
patients with markedly reduced systolic function, an
additional analysis was carried out in the 159 patients
with EF #35%. In this subgroup, LV ﬁlling pressure
could not be assessed by echocardiography in 11
patients (indeterminate per the algorithm). In 129
patients with low EF and elevated LV ﬁlling pressure
by cardiac catheterization, the algorithm correctly
identiﬁed elevated ﬁlling pressure in 117 (91%); in 12,
however, ﬁlling pressure was incorrectly classiﬁed as
normal. Prediction was correct in 18 of the 19 (95%)
patients with normal LV ﬁlling pressure; the incorrect
prediction in 1 patient was elevated. When testingaverage E/e0 ratio as a single predictor of LV ﬁlling
pressure, in these patients with low EF, prediction
was correct in 18 of 24 (75%) with normal ﬁlling
pressure during cardiac catheterization. Of the 135
patients with elevated LV ﬁlling pressure, prediction
by E/e0 was correct in 111 (82%).
LV ﬁlling pressure was signiﬁcantly different be-
tween the 3 grades of diastolic dysfunction (analysis
of variance on ranks: p < 0.001). It increased from
10 mm Hg in grade I (interquartile range [IQR]: 7 to
12 mmHg) to 18 mm Hg in grade II (IQR: 14 to 24 mmHg)
and 24 mm Hg in grade III (IQR: 19 to 30 mm Hg) (grade I
vs. grade II: p < 0.001; grade I vs. grade III: p < 0.001;
grade II vs. grade III: p ¼ 0.006 by Dunn method).
ECHOCARDIOGRAPHIC ASSESSMENT OF FILLING
PRESSURES VERSUS CLINICAL EVALUATION. Clin-
ical assessment of LV ﬁlling pressure was feasible in
448 of 450 (99.6%) patients; clinical status could not
be reliably assessed in 2 patients. The echocardio-
graphic approach was feasible in 419 (93.1%) and
inconclusive in 31 due to inability to acquire the
complete set of signals needed for estimating PCWP
as recommended in the guidelines. The comparison
of clinical diagnosis against echocardiographic diag-
nosis of elevated ﬁlling pressure (with invasive mea-
surement as the gold standard) is presented in Tables 4
and 5. The clinical diagnosis of HF and normal LVEF
had a sensitivity of 45%, a speciﬁcity of 76%, and an
accuracy of 64% in identifying patients with HFpEF
(13). N-terminal pro–B-type natriuretic peptide (NT-
proBNP) levels obtained on the same day as cardiac
catheterization were related to LV ﬁlling pressure in a
subset of 123 patients. In 41 patients with normal LVEF
and normal LV ﬁlling pressure, NT-proBNP levels
were <300 pg/ml, and levels were elevated and
consistent with increased ﬁlling pressure in 7 patients
who met the invasive diagnostic criteria of HFpEF.
However, the biomarker level was also elevated in 7
patients with normal LV ﬁlling pressure and normal
EF, andwas<300 pg/ml in another 12 patients who had
an LV ﬁlling pressure >12 mm Hg. NT-proBNP levels
correctly identiﬁed 28 patients with depressed LVEF
and elevated LV ﬁlling pressure and 5 patients with
depressed LVEF and normal LV ﬁlling pressure. How-
ever, 17 patients with depressed EF and elevated LV
ﬁlling pressure and 2 with normal LV ﬁlling pressure
were not correctly identiﬁed by NT-proBNP levels.
On logistic regression analysis, AUC increased
from 0.71 for clinical assessment to 0.87 for echo-
cardiographic assessment to 0.91 for the combina-
tion of clinical and echocardiographic assessments
(p ¼ 0.0002 vs. echocardiographic assessment only
and p < 0.001 vs. clinical assessment only). Global
TABLE 4 Accuracy of Diagnosis of Elevated LV Filling Pressure:
Total Population
Clinical
(95% CI)
Echocardiographic
(95% CI)
p Value*
Clinical vs. Echo
Sensitivity 74 (68–79) 87 (81–91) 0.001
Speciﬁcity 69 (62–75) 88 (82–93) <0.001
PPV 77 (71–82) 91 (86–94) <0.001
NPV 65 (58–72) 83 (76–88) <0.001
Overall
accuracy
72 (67–76) 87 (84–91) <0.001
Values are %. *Based on McNemar test.
CI ¼ conﬁdence interval; echo ¼ echocardiography; NPV ¼ negative predictive
value; PPV ¼ positive predictive value; other abbreviations as in Table 1.
TABLE 3 Distribution of 2D and Doppler Variables*
Elevated Filling
Pressure
(n ¼ 165)
Normal Filling
Pressure
(n ¼ 155)
Mitral E/A ratio #0.8 þ E #50 cm/s 0 23
Mitral E/A ratio $2 53 5
None of the cutoff values met for the 3 variables in patients
with diastolic dysfunction†
15 70
3 abnormal LAV >34 ml/m2, E/e0 >14,
and TRV >2.8 m/s
25 0
2 abnormal (2 of 3 listed) LAV >34 ml/m2, E/e0 >14,
TRV <2.8 m/s
35 7
LAV >34 ml/m2, E/e0 <14,
TRV >2.8 m/s
11 8
LAV <34 ml/m2, E/e0 >14,
TRV >2.8 m/s
8 1
1 abnormal LAV >34 ml/m2 6 32
E/e0 >14 8 4
TR >2.8 m/s 4 5
Values are n. *In patients in sinus rhythm and without atrial ﬁbrillation, paced rhythm, or signiﬁcant mitral
regurgitation where a conclusion on LV ﬁlling pressure could be reached. †Diastolic dysfunction was diagnosed
based on the presence of pathological LV hypertrophy, coronary artery disease (CAD), and/or depressed LVEF.
TRV ¼ tricuspid regurgitation velocity; other abbreviations as in Table 1.
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1945chi-square analysis showed a signiﬁcant increment
when clinical and echocardiographic data were com-
bined (259.14 vs. 240.55 for echocardiography only
and 83.16 for clinical evaluation only; p < 0.0001 vs.
clinical evaluation only and vs. echocardiography
alone). Net reclassiﬁcation improvement for the
combination of echocardiography and clinical
assessment over clinical assessment alone was 1.5
(p < 0.0001) as was the IDI at 0.293 (p < 0.0001). The
combination of both clinical and echocardiographic
assessment over echocardiographic assessment alone
was smaller at 1.08 but was still signiﬁcant
(p < 0.0001); the same trend was observed for IDI
analysis at 0.034 (p ¼ 0.0002).
Echocardiographic accuracy in detecting elevated
PCWP was 91% in patients with EF <50% and 84% in
patients with EF $50% (Table 5). The echocardio-
graphic diagnosis of elevated LV ﬁlling pressure
against the invasive gold standard was good for
patients with LBBB or a paced rhythm (AUC ¼ 0.84),
AF (AUC ¼ 0.83), or moderately-severe to severe
MR (AUC ¼ 0.96). For these disorders, the speciﬁc
approach recommended in the guidelines was
applied (5).
DISCUSSION
The current study demonstrated that echocardiogra-
phy can reliably identify patients with elevated LV
ﬁlling pressure with high feasibility and good accu-
racy. This was observed in a large sample from mul-
tiple institutions, including several patients who pose
challenges to the acquisition and interpretation of
echo data. Our study validated the recently published
ASE/European Association of Cardiovascular Imaging
(EACVI) guidelines (5).
The study was unique given the large sample size,
the inclusion of patients with a wide spectrum of
underlying cardiac diseases, and a proportion of pa-
tients with normal LVEF, which is consistent with
what is seen in clinical practice (4). As recommended
in the guidelines, the study combines LA volume in-
dex as an indicator of long-term elevation of LV ﬁlling
pressure with Doppler velocities, which reﬂect ﬁlling
pressure at the time of echocardiographic examina-
tion (5). Given the performance of individual signals,
an approach combining different measurements, as
recommended in the 2016 guidelines, is essential to
correctly estimate LV ﬁlling pressure.
ECHOCARDIOGRAPHIC ESTIMATION OF LV FILLING
PRESSURE BY EF. Patients with depressed LVEF and
normal wedge pressure usually have an impaired LV
relaxation pattern. However, when LV ﬁlling pressure
increases, predominant early diastolic ﬁlling occurs(grade II and III diastolic dysfunction) with short
deceleration time and isovolumic relaxation time,
elevated E/e0 ratio, and increased pulmonary artery
pressures. These ﬁndings were veriﬁed in stable pa-
tients with HFrEF (14–24) as well as in patients with
acute decompensated heart failure (6,25). The current
study supports the important role of echocardiogra-
phy in estimating LV ﬁlling pressure in patients with
HFrEF, where concerns were raised about the accu-
racy of single indexes and reproducibility of tech-
nique (26,27). These concerns were expressed despite
numerous published studies from several laboratories
across the globe showing not only the diagnostic
aspect of the methodology but also its ability to pre-
dict outcome events. Notably, some of the studies
tried to apply the methodology to patients with
normal EF, but without cardiac disease where the
hemodynamic variables that affect Doppler signals
FIGURE 4 Evaluation of Diastolic Function and LV Filling Pressure
Evaluation of diastolic
function in
asymptomatic patients
Normal clinical
findings and normal
2D echo
Normal clinical
findings and 2D echo
Evaluate annular e’ velocity,
LA maximum volume index,
average E/e’ ratio, peak TR velocity
Diastolic
dysfunction
absent
Consider above signals
in addition to other
measurements as GLS,
MAPSE and LA strain
Apply algorithm in the
 Central Illustration to 
 determine if LVFP
is elevated
Diastolic
dysfunction
Present
Indeterminate
Evaluation of diastol
(LVFP) in
To identify patients with cardiac disease in whom the algorithm (Centra
2-dimensional (2D) ﬁndings, followed by Doppler signals, and if needed
diastolic stress testing. For diastolic function assessment in the absence o
annular velocities, LA maximal volume index, average E/e0 ratio, and pe
that point to cardiac disease could be considered, including LV global lo
(MAPSE), and LA strain. The latter approach needs validation. CHF ¼ co
ventricular ﬁlling pressure; other abbreviations as in Figure 1.
TABLE 5 Accuracy of Diagnosis of Elevated LV Filling Pressure:
Subgroup Analysis
Clinical
Accuracy
Echocardiographic
Accuracy
p Value
Clinical
vs. Echo
LVEF <50% (n ¼ 209) 81 91 0.01
LVEF $50% (n ¼ 241) 64 84 <0.001
Obesity (n ¼ 193) 76 87 0.015
Diabetes mellitus (n ¼ 48) 70.8 88 0.08
Chronic kidney disease (n ¼ 47) 61.7 79 0.12
Hypertension (n ¼ 167) 68 86.7 <0.001
CAD (n ¼ 155) 73.5 92.7 <0.001
Pulmonary parenchymal or
vascular disease (n ¼ 71)
53.5 81 0.001
Values are %.
Abbreviations as in Tables 1, 3, and 4.
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1946are different from those in patients with abnormal
myocardial function (for example mitral annulus e0
velocity, which is directly related to ﬁlling pressure in
normal subjects). Other studies had technically chal-
lenging signals that were nevertheless still used to
derive conclusions or used the same general approach
to special patient groups where a speciﬁc approach is
recommended. Patients with EF <50% constituted
46% of our study population, and we noted similar
results. The comprehensive approach recommended
in the 2016 guidelines improved the diagnostic accu-
racy, which was 81% for clinical assessment alone to
91% by echocardiography (Table 5).
Estimation of LV ﬁlling pressure is more chal-
lenging in patients with normal EF. In our study, in-
dividual 2D and Doppler signals had signiﬁcant butDyspnea due
to elevated
LVFP and
CHF is
confirmed
Dyspnea not
due to elevated
LVFP at rest
Consider invasive
study: LV cath or right
heart cath at rest or
both at rest and
exercise
If concerns remain about cardiac etiology, then
noninvasive diastolic stress test or if
inconclusive, invasive diastolic stress test.
LVFP
elevated
LVFP
normal
LVFP
indeterminate
Apply algorithm in central illustration
to determine if LVFP is elevated 
Clinical and or 2D echo
consistent with cardiac disease
ic function and LV filling pressure
 patients with dyspnea
l Illustration) can be applied, the evaluations start with clinical and
, cardiac catheterization with or without noninvasive or invasive
f abnormal clinical and 2D ﬁndings, the evaluation begins with mitral
ak TR signal. When ﬁndings are indeterminate, other abnormalities
ngitudinal strain (GLS), mitral annulus systolic plane excursion
ngestive heart failure; echo ¼ echocardiography; LVFP ¼ left
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Combining
echocardiographic measures of left atrial volume index with
diastolic Doppler ﬁlling velocity can identify patients with
elevated LV ﬁlling pressure and, when interpreted in conjunction
with clinical data, enhances diagnostic accuracy, regardless of LV
ejection fraction.
TRANSLATIONAL OUTLOOK: Additional studies are needed
to assess the utility of echocardiographically estimated LV ﬁlling
pressure to guide therapy for patients with and without heart
failure.
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1947modest relations with LV ﬁlling pressure, similar to
previous studies (19–22). However, a comprehensive
approach, as recommended in the guidelines, resul-
ted in good accuracy that surpassed clinical assess-
ment alone (84% vs. 64%; p < 0.001).
CLINICAL IMPLICATIONS. There are practical impli-
cations to our ﬁndings, as patients with previous HF
history, whether with normal or reduced EF, can have
other reasons for dyspnea, such as chronic obstruc-
tive pulmonary disease. By accurately identifying the
correct cause of dyspnea in a patient, the appropriate
treatment can be implemented.
The starting point for evaluation is the history and
physical examination and, as needed, chest x-ray and
laboratory tests. In some patients, this can be enough
to reach the correct diagnosis. However, there are
challenges for clinical assessment, as noted in this
study for obese patients and for patients with pul-
monary disease, 2 groups with a high frequency of
concomitant cardiac pathology. Our ﬁndings high-
lighted the important role of echocardiography in
estimating LV ﬁlling pressure in patients who pose
problems to clinical evaluation.
Many clinicians utilize echocardiography mainly to
assess LV volumes and EF in trying to draw conclu-
sions about the etiology of dyspnea. LV ﬁlling param-
eters are often overlooked and some physicians
assume that patients with depressed EF have elevated
LV ﬁlling pressure as the reason for shortness of
breath. We have shown that this is not the case for 40%
of patients with LV systolic dysfunction and depressed
EF, highlighting the need to acquire and analyze
Doppler signals in this patient population. Likewise,
although themajority of patients (57%) with normal EF
had elevated LV ﬁlling pressure, many patients did
not. Figure 4 presents our recommended approach to
the evaluation of patients suspected of having dys-
pnea due to elevated LV ﬁlling pressure.
STUDY LIMITATIONS. The current ASE/EACVI algo-
rithm recommends performing the diastolic stress test
in symptomatic patients who have normal ﬁlling
pressure at rest. Stress testing was not performed, and
it is possible that echocardiographic Doppler mea-
surements during exercise could have revealed
elevated ﬁlling pressure in some of these patients
(28,29). For other subgroups with nonsinus rhythm
and for patients with hemodynamically signiﬁcantMR, the existing echocardiographic methodology is
promising but needs additional validation in larger
samples given the small number of patients in these
subgroups in our study. The algorithm is based on the
interpretation of 2D and Doppler signals in patients
with cardiovascular diseases and not in patients
without cardiac diseases, who are explicitly excluded
from the algorithm (5). The accuracy of echocardio-
graphic evaluation of LV ﬁlling pressure likely will be
lower when applied in populations with lower preva-
lence of cardiac disease. Echocardiography and car-
diac catheterization were not simultaneous in all
patients. However, there were no signiﬁcant differ-
ences in heart rate and blood pressure between the 2
studies. The evaluation of the accuracy of clinical and
echocardiographic assessment was performed in the
same sample and needs validation in a separate group.
CONCLUSIONS
Echocardiographic assessment of LV ﬁlling is readily
available with high feasibility and good accuracy to
estimate LV ﬁlling pressure. Our study validated the
recently published ASE/EACVI guidelines. When used
in the proper context, it leads to a more accurate
diagnosis of elevated LV ﬁlling pressure, irrespective
of LVEF.
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